Guidelines for Avoiding Risks Resulting From Discontinuation of Nucleoside/Nucleotide Analogs in Patients With Chronic Hepatitis B
Hepatology Research - United Kingdom
doi 10.1111/hepr.12108
Full Text
Open PDFAbstract
Available in full text
Date
May 7, 2013
Authors
Publisher
Wiley